| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | United States | 2 | |
| #4 | Australia | 1 | |
| #5 | China | 1 | |
| #6 | Israel | 1 | |
| #7 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Luk John Moonching | 10 |
| #2 | Staunton Donald E | 8 |
| #3 | Stauton Donald E | 6 |
| #4 | Li Zhijie | 3 |
| #5 | Harlan John M | 1 |
| #6 | Jin David Kin | 1 |
| #7 | Stauton Donald | 1 |
| #8 | Luk John | 1 |
| #9 | Luk John M | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020172641A1 | Artificial immunosurveillance chimeric antigen receptor and cells expressing the same | |
| WO2020146857A1 | Multispecific prochemokine therapeutic proteins (park) and method of making and using thereof | |
| US2021116456A1 | Compositions and methods for diagnosis and treatment of cancer | |
| US2021115152A1 | Composition of bispecific antibodies and method of use thereof | |
| CN108778327A | 7 specific antibody of Epithelial-Cadherin and cytotoxic cell use for cancer treatment |